23andMe's CEO Anne Wojcicki 'Disappointed' at Board Shakeup as All Seven Independent Directors Resign

  • yesterday
All seven independent directors of 23andMe resigned from the board, citing disagreements with CEO Anne Wojcicki regarding the company’s strategic direction. Wojcicki expressed "disappointment" in the resignations but reaffirmed her commitment to taking the genetic-testing company private despite a rejected proposal in July. The special committee found no actionable proposal benefiting non-affiliated shareholders. 23andMe, which went public via a SPAC in 2021, has seen its share price drop over 95%, closing at 34 cents on Tuesday.

Category

🗞
News

Recommended